SCS adds to iPS portfolio

By Dylan Bushell-Embling
Wednesday, 08 October, 2008

Stem Cell Sciences [ASX: STC] has licensed technology developed at Cambridge University used to reprogram adult cells into stem cells.

The agreement relates specifically to patents for technology used to generate induced pluripotent stem (iPS) cells from mammalian cells.

The technology was developed by Professor Austin Smith. Smith, director of the Wellcome Trust Centre for Stem Cell Research.

Smith also serves as chairman of SCS's Scientific Advisory Board.

Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

Content from other channels on our network

Victorian businesses encouraged to join WaterSmart program

How Australia's built environment is navigating sustainability communications

Real-time metering upgrade for Melbourne

Partnership launches Living Lab to test decarbonisation tech

The hidden sustainability opportunity in Australia's construction

Plan for food security in the face of supply chain issues

Small brewery keeps the beer flowing with Macquarie Telecom

Food Standards Board appoints new Acting Chair

Low-methane Angus beef on the shelves at Foodland in SA

FSANZ approves caffeine proposal and formula additive

Why AI security is now a patient-safety issue

Construction commences on $100m New Epping Medical building

Balcony and nearby construction activities linked to RPA deaths

$10K fine for former nurse who forged registration certificates

Australian 'falls after stroke trial' sees 33% falls reduction in 12 months